FDA Issues Reminder on Risk for Methemoglobinemia with Topical Benzocaine - Physician's First Watch
Links shared publicly online about this topic.
- 320total visits
FDA Issues Reminder on Risk for Methemoglobinemia with Topical Benzocaine - Physician's First Watch
The FDA is reminding healthcare providers that benzocaine sprays, gels, and liquids carry an increased risk for methemoglobinemia. The product labels do not currently warn about this risk. To date, there have been 319 reported . . . LINK(S):
View full resource at firstwatch.jwatch.org
Tags: Healthcare, FDA, Physician
Most Recently Shared on May 3, 2011 at 1:11 pm By:
Benzocaine sprays, gels, and liquids carry an increased risk for methemoglobinemia. http://t.co/ElNYNtO
Advertisement
